Karriereverlauf von Christina Trojel-Hansen
Ehemalige bekannte Positionen von Christina Trojel-Hansen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Oscine Corp.
 Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Vorstandsvorsitzender | 01.09.2017 | 01.09.2020 |
| Gründer | - | 01.09.2020 | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Private-Equity-Analyst | 01.02.2016 | 01.04.2018 |
Statistik
International
| Dänemark | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Private Equity Analyst | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Finance |
Oscine Corp.
Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Health Technology |
- Börse
- Insiders
- Christina Trojel-Hansen
- Erfahrung
